Interestingly, individuals with low levels of GIP may also have low levels of GLP-1 and vice versa (49)
Special considerations for oral and alternative GLP-1 formulations Not all GLP-1 medications are injectable
The GIP receptor component enhances insulin secretion and may reduce nausea associated with GLP-1 activation
Daily observations: Appetite level (1-10 scale), nausea level (0-5 scale), energy level, any notable GI symptoms, bowel changes, mood or sleep changes
It is not approved for human or veterinary therapeutic use
For patients using currently available injectable GLP-1 medications , common errors include injecting into the same site repeatedly, failing to allow refrigerated medication to reach room temperature before injection, not rotating injection sites properly, and incorrect pen device technique